Asthma and COVID-19: risks and management considerations, CEBM

VERDICT: It is unclear if people with asthma are at increased risk of contracting COVID-19 or of worse outcomes from COVID-19 infection. The evidence available is limited with some sources suggesting an underrepresentation of PWA in hospitalised cases, and others showing an increased risk of worse outcomes in PWA which may be associated with disease severity. Consensus broadly holds that asthma medications should be continued as usual. Asthma care may be disrupted during the pandemic; self-management and remote interventions may be of benefit but have not been tested in this context.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Asthma | COVID-19 | Health | Pandemics